Full Breakdown
Jacob deGrom Rejects Trade to Braves, Commits to Texas Rangers
8/5/2026, 5:05:17 PM
Core Event: No-Trade Clause Keeps DeGrom in Texas
On the 2026 MLB trade deadline, starting pitcher Jacob deGrom exercised the full no-trade clause in his contract and declined an offer from the Atlanta Braves. Rangers officials indicated they would facilitate a deal if he waived the clause, but deGrom chose to remain with Texas, ending any possibility of a mid-season move.
Background & Context
DeGrom signed a five-year, $185 million free-agent contract with the Rangers in December 2022, with a conditional club option for 2028 ranging from $20 million to $37 million. In 2023 the Rangers captured the World Series, with deGrom posting a 2-0 record, a 2.67 ERA and 45 strikeouts in six starts. He underwent Tommy John surgery in 2024, missing most of that season and returning for the final three games. The 2026 season is his fourth year of the contract and the final full season before the optional 2028 year.
Timeline
- December 2022 – DeGrom signs five-year, $185 million contract.
- 2023 season – Rangers win World Series; deGrom contributes 2-0 with a 2.67 ERA.
- May–June 2024 – Tommy John surgery; misses bulk of season.
- 2025 season – Posts a 7-7 record with a 3.96 ERA (21 starts).
- August 1, 2026 – Reports that the Braves pursued deGrom before the deadline.
- August 4, 2026 – Rangers sit 2.5 games behind in the AL West and two games back in the Wild Card race.
Data & Statistics
- 2026: 7-7 record, 3.96 ERA, 135 strikeouts, 29 walks over 113.2 innings (21 starts).
- 2023: 2-0 record, 2.67 ERA, 45 strikeouts in six starts.
- Career highlights: Two consecutive Cy Young Awards (2018, 2019) with the Mets.
Official Statements & Responses
DeGrom told reporters his decision was driven by a desire to stay in Texas, confidence in the roster and a personal goal of helping the Rangers win another World Series. Ken Rosenthal of *The Athletic* reported that the Braves formally expressed interest and that Rangers officials offered a trade if deGrom waived his clause; he declined.
Why It Matters
Keeping deGrom preserves a high-caliber arm for the Rangers as they chase a postseason berth, while the Braves miss a chance to bolster a rotation already hampered by injuries. The decision also underscores the strategic value of no-trade clauses for elite players seeking control over their careers.
Conflicting Reports & Gaps
All available sources agree that deGrom refused the Braves’ overture and remained with the Rangers. No substantive discrepancies have been identified regarding the core facts of the trade-deadline decision.
What’s Next
DeGrom has one year remaining on his contract, with the 2028 club option pending. His health and performance for the rest of the 2026 season will shape both his legacy and the Rangers’ postseason prospects.
